Insmed (Nasdaq:INSM) is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. Our strong and experienced management team embodies our culture, setting the tone for an organization that acts boldly, thinks creatively, and puts patients first in everything we do.
Explore the Investor Relations Center to learn more about our company.
Download the Investor Presentation
 |
2022 Responsibility Report |
Our inaugural Responsibility Report reflects the culture and purpose we live by every day. We are committed to reporting annually on our progress and commitments.
 |
As a champion for the rare disease community, we are dedicated to supporting patients and their families along their journey.
 |
Stay in the loop
Want to stay up to date on our news,
events, and filings? Set up your email
alerts.
Investor Presentation
View the latest Insmed Investor
Presentation here.
Investor & Media Contacts
Investors
Bryan Dunn
Executive Director, Investor Relations, Insmed
(646) 812-4030
Eleanor Barisser
Associate Director, Investor Relations, Insmed
(718) 594-5332
